Fundz

Aquestive Therapeutics Appoints Dr. Matthew Greenhawt as Chief Medical Officer

PUBLIC · AQSTFeb 18, 2026

Position

Chief Medical Officer

Company

Aquestive Therapeutics, Inc.

Matthew Greenhawt
WarrenBiotechnologyHealthcareHealth CareMedicalTherapeuticsPharmaceuticalBiopharma

Description

Aquestive Therapeutics announces the appointment of Dr. Matthew Greenhawt as Chief Medical Officer. His expertise in allergy and immunology will strengthen the leadership team as the company prepares to resubmit its Anaphylm NDA to the FDA.

Other recent leadership changes in Healthcare and Medical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Aquestive Therapeutics, Inc., and when

A new leader at Aquestive Therapeutics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Aquestive Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aquestive Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aquestive Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aquestive Therapeutics, Inc.

Location

30 TECHNOLOGY DRIVE SOUTH

Warren, New Jersey, United States

About

Aquestive Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs. The company specializes in drug delivery technologies and is committed to improving patients' lives through its product pipeline. Their product candidate, Anaphylm™, aims to provide a new treatment option for severe allergic reactions. The company is headquartered in Warren, New Jersey.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aquestive Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Milosz
Senior decision-maker at this company
••••••••@••••••••

See Milosz's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aquestive Therapeutics, Inc.'s next move

Learn about Strategic plan

Aquestive Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.